Miguel Gómez Álvarez and Carlos Vallejo/X
Jun 12, 2026, 16:12
Miguel Gómez Álvarez: The Evidence on Disease Burden in PNH
Miguel Gómez Álvarez, Hematologist at Department of Hematology and Hemotherapy, Hospital Clínico San Carlos, Madrid, Spain, shared a post on X:
“Carlos Vallejo presents the evidence on the disease burden in PNH:
The importance of fatigue in patients already treated with iC5, the impact on quality of life, and the relevance of shared decision-making.”
Stay updated with Hemostasis Today.
-
Jul 28, 2026, 15:31Nancy Di Salvo: UNITAR and GBS|CIDP Foundation International Unite to Advance Plasma4Life
-
Jul 28, 2026, 15:30Alfonso J. Tafur: What Patients Fear Most When Anticoagulation Is Interrupted
-
Jul 28, 2026, 15:09John Perrier: Connecting Through Science at ISTH 2026
-
Jul 28, 2026, 15:00Rucha Patil: Grateful to Contribute to the National Coagulation Conclave 2026
-
Jul 28, 2026, 14:51Islam Aboumoussa: A New Perspective on Dual Antithrombotic Therapy in Stroke Prevention
-
Jul 28, 2026, 14:40Marilena Vrana: Join the Conversation at Plasma Protein Forum 2026
-
Jul 28, 2026, 14:24Jon Wright: Pushing the Boundaries of Hemophilia Care
-
Jul 28, 2026, 14:11Improving Care for People with Bleeding Disorders Through Teamwork – WFH
-
Jul 28, 2026, 14:10Blessing Oluwasanya: When Heavy Periods Are More Than Just an Inconvenience